[1]雷肖蠢,邱军杰,王西辉.小剂量盐酸替罗非班联合急诊冠脉介入在心肌梗死患者中的临床效果及安全性[J].中国医学物理学杂志,2017,34(12):1241-1245.[doi:DOI:10.3969/j.issn.1005-202X.2017.12.010]
　LEI Xiaochun,QIU Junjie,WANG Xihui. Clinical efficacy and safety of low dose tirofiban hydrochloride combined with emergency coronary intervention in patients with myocardial infarction[J].Chinese Journal of Medical Physics,2017,34(12):1241-1245.[doi:DOI:10.3969/j.issn.1005-202X.2017.12.010]
点击复制

小剂量盐酸替罗非班联合急诊冠脉介入在心肌梗死患者中的临床效果及安全性()
分享到：

《中国医学物理学杂志》[ISSN:1005-202X/CN:44-1351/R]

卷:
34卷
期数:
2017年第12期
页码:
1241-1245
栏目:
医学影像物理
出版日期:
2017-12-20

文章信息/Info

Title:
 Clinical efficacy and safety of low dose tirofiban hydrochloride combined with emergency coronary intervention in patients with myocardial infarction
文章编号:
1005-202X（2017）12-1241-05
作者:
雷肖蠢; 邱军杰; 王西辉
西安医学院第二附属医院心内科， 陕西 西安 710038
Author(s):
 LEI Xiaochun;  QIU Junjie;  WANG Xihui
 Department of Cardiology, the Second Affiliated Hospital of Xi’an Medical University, Xi’an 710038, China
关键词:
 ; 盐酸替罗非班; 急诊; 冠脉介入; 心肌梗死; 临床效果; 安全性
Keywords:
 ; Keywords: tirofiban hydrochloride;  emergency coronary;  intervention;  myocardial infarction;  clinical efficacy;  safety
分类号:
R542.22
DOI:
DOI:10.3969/j.issn.1005-202X.2017.12.010
文献标志码:
A
摘要:
 目的：综合分析小剂量盐酸替罗非班联合急诊冠脉介入在心肌梗死患者中的临床效果及安全性，为治疗心肌梗死患者提供科学的数据参考。 方法：选取2013年10月~2016年10月收治的110例心肌梗死患者，根据患者的意愿随机分为试验组（应用小剂量盐酸替罗非班联合急诊冠脉介入治疗方法）与对照组（应用急诊冠脉介入治疗方法联合常规剂量盐酸替罗非班），每组均为55例。采用SPSS 20.0统计学软件进行统计学分析两组患者的发病至介入时间、心血管发生情况、出血并发症发生率以及急诊冠脉介入手术前后TIMI血流分级情况。 结果：（1）两组患者在发病至介入时间比较无统计学意义（P>0.05）；（2）试验组患者住院期间心血管发生率为0.00%（0/55），对照组患者住院期间心血管发生率为7.28%（4/55），试验组患者住院期间心血管发生率显著低于对照组患者（P<0.05）；（3）急诊冠脉介入手术前，两组患者在TIMI 2级和TIMI 3级比较无统计学意义（P>0.05），在TIMI 0级和TIMI 1级比较有统计学意义（P<0.05），急诊冠脉介入手术后，两组患者在TIMI 0~2级、TIMI 3级比较有统计学意义（P<0.05）。 结论：小剂量盐酸替罗非班联合急诊冠脉介入在心肌梗死患者中的临床效果显著且具有高度的安全性。
Abstract:
Abstract: Objective To analyze the clinical efficacy and safety of low dose tirofiban hydrochloride combined with emergency coronary intervention in patients with myocardial infarction, and to provide reference data for the treatment of patients with myocardial infarction. Methods Admitted to the Second Affiliated Hospital of Xi’an Medical University between October 2013 and October 2016, 110 patients with myocardial infarction were randomly divided into experimental group and control group, with 55 patients in each group. The patients in experimental group were treated with low dose tirofiban hydrochloride combined with emergency coronary intervention, while those in control group received emergency coronary intervention therapy combined with conventional dose tirofiban hydrochloride. SPSS 20.0 statistical software was used to analyze the time between onset and intervention, the occurrence of cardiovascular diseases, the incidence of bleeding complications and the thrombolysis in myocardial infarction (TIMI) blood flow before and after emergency coronary intervention. Results No significant differences were found between two groups in the time between onset and intervention (P>0.05). The incidence of cardiovascular disease in experimental group was 0.00% (0/55) as compared with 7.28% (4/55) in control group, with statistical differences (P<0.05). Before emergency coronary intervention, the comparison between two groups showed significant differences in TIMI grade 0 and 1 (P<0.05), but not in TIMI grade 2 and 3 (P>0.05). After emergency coronary intervention, two groups had significant differences in TIMI grade 0-2 and 3 (P<0.05). Conclusion Low dose tirofiban hydrochloride combined with emergency coronary intervention in patients with myocardial infarction has significant clinical efficacy and high safety.

相似文献/References:

[1]王遥,霍万里,熊壮,等.TACE手术中不同站姿下铅眼镜和铅面罩对医生眼晶状体防护效果的蒙特卡洛模拟比较[J].中国医学物理学杂志,2016,33(6):553.[doi:DOI:10.3969/j.issn.1005-202X.2016.06.003]
　[J].Chinese Journal of Medical Physics,2016,33(12):553.[doi:DOI:10.3969/j.issn.1005-202X.2016.06.003]
[2]张新,谷晓芳,王培臣,等.轻离子束治疗设备注册检验关键技术问题[J].中国医学物理学杂志,2016,33(6):559.[doi:10.3969/j.issn.1005-202X.2016.06.004]
　[J].Chinese Journal of Medical Physics,2016,33(12):559.[doi:10.3969/j.issn.1005-202X.2016.06.004]
[3]江芬芬,王培,康盛伟,等. 热释光剂量片测量肺部肿瘤放疗剂量的方法[J].中国医学物理学杂志,2016,33(6):564.[doi:10.3969/j.issn.1005-202X.2016.06.005]
　[J].Chinese Journal of Medical Physics,2016,33(12):564.[doi:10.3969/j.issn.1005-202X.2016.06.005]
[4]刘洪源,彭威,杨锐,等. 锥形束CT离线校正肺癌摆位误差[J].中国医学物理学杂志,2016,33(6):573.[doi:10.3969/j.issn.1005-202X.2016.06.007]
　[J].Chinese Journal of Medical Physics,2016,33(12):573.[doi:10.3969/j.issn.1005-202X.2016.06.007]
[5]赵彪,潘香,杨毅,等. 右乳癌保乳术后瘤床同步X线和后程电子线补量调强放疗剂量学比较[J].中国医学物理学杂志,2016,33(6):576.[doi:10.3969/j.issn.1005-202X.2016.06.008]
　[J].Chinese Journal of Medical Physics,2016,33(12):576.[doi:10.3969/j.issn.1005-202X.2016.06.008]
[6]邓南,钱建庭,刁现芬,等. 基于宽带检测放疗X-光光声效应仿体实验[J].中国医学物理学杂志,2016,33(9):865.[doi:DOI:10.3969/j.issn.1005-202X.2016.09.001]
　[J].Chinese Journal of Medical Physics,2016,33(12):865.[doi:DOI:10.3969/j.issn.1005-202X.2016.09.001]
[7]张先稳,李军,张西志,等. 宫颈癌术后5野调强放疗4个变量组合的最佳治疗模式的剂量学[J].中国医学物理学杂志,2016,33(9):872.[doi:10.3969/j.issn.1005-202X.2016.09.002]
　[J].Chinese Journal of Medical Physics,2016,33(12):872.[doi:10.3969/j.issn.1005-202X.2016.09.002]
[8]胡健,李承军,徐利明,等. 床面倾斜对剂量验证通过率的影响[J].中国医学物理学杂志,2016,33(9):881.[doi:10.3969/j.issn.1005-202X.2016.09.003]
　[J].Chinese Journal of Medical Physics,2016,33(12):881.[doi:10.3969/j.issn.1005-202X.2016.09.003]
[9]陈亚正,肖明勇,孙春堂,等. 准直器角度对宫颈癌术后VMAT计划的影响[J].中国医学物理学杂志,2016,33(9):885.[doi:10.3969/j.issn.1005-202X.2016.09.004]
　[J].Chinese Journal of Medical Physics,2016,33(12):885.[doi:10.3969/j.issn.1005-202X.2016.09.004]
[10]李毅,唐丰文,张晓智. 基于四维CT和锥形束CT确定非小细胞肺癌放疗靶区外放边界[J].中国医学物理学杂志,2016,33(9):892.[doi:10.3969/j.issn.1005-202X.2016.09.005]
　[J].Chinese Journal of Medical Physics,2016,33(12):892.[doi:10.3969/j.issn.1005-202X.2016.09.005]

备注/Memo

备注/Memo:
 【收稿日期】2017-09-28
【基金项目】陕西省教育厅专项科研计划项目（16JK1667）
【作者简介】雷肖蠢，主治医师，研究方向：冠脉介入方向，E-mail: 709151105@qq.com
【通信作者】王西辉，副主任医师，中华医学会陕西省心血管分会委员，E-mail: 851463366@qq.com
更新日期/Last Update: 2017-12-21